Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Quote

Not a forecast

“That's why I'm excited about medicines like Cobenfy—the very first novel and psychotic that doesn't cause weight gain—and doesn't cause movement disorders, and that's available for people with psychosis now.”
· This Physician Realizes He Might Have The Movement Disorder He's Been Researching. · substack post

Closing argument for safer options than dopamine-blocking antipsychotics; the author praises Cobenfy as the first novel antipsychotic that causes neither weight gain nor movement disorders and is available now for psychosis.

Descriptive, retrospective, or a statement of preference; no future state asserted.